Lehrstuhl für Innere Medizin III


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Deletion of the Casp8 gene in mice results in ileocolitis, gut barrier dysfunction, and malassimilation, which can be partially attenuated by inulin or sodium butyrate. (2019) Günther C, Kaden-Volynets V, Zimmermann J, Beisner J, Becker C, Bischoff SC Journal article Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course (2019) Cavagna L, Trallero-Araguas E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, et al. Journal article Regulation of Fibroblast Apoptosis and Proliferation by MicroRNA-125b in Systemic Sclerosis (2019) Kozlova A, Pachera E, Maurer B, Juengel A, Distler J, Kania G, Distler O Journal article Höhere Prävalenz von depressiven und ängstlichen Symptomen bei Früharthritispatienten im Vergleich zur Normalbevölkerung (2019) Freier D, Englbrecht M, Höhne-Zimmer V, Detert J, Burmester GR Journal article The Role of Dietary Fiber in Rheumatoid Arthritis Patients: A Feasibility Study (2019) Häger J, Bang H, Hagen M, Frech M, Träger P, Sokolova MV, Steffen U, et al. Journal article Anti-citrullinated Vimentin Antibodies Are Associated to Early Deterioration of Cortical Bone and Volumetric Bone Mineral Density in Finger Joints in RA-at-risk Patients (2019) Schett G, Simon D, Hueber A, Bang H, Rech J, Krönke G, Kleyer A Conference contribution Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease by Use of Mycophenolate at Baseline: Subgroup Analysis of the SENSCIS Trial (2019) Highland K, Distler O, Kuwana M, Allanore Y, Assassi S, Azuma A, Bourdin A, et al. Conference contribution Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial (2019) Mayes M, Highland K, Gahlemann M, Fischer A, Raghu G, Girard M, Alves M, et al. Conference contribution The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases (2019) Matteson E, Kelly C, Distler J, Mann-Vold AMH, Seibold J, Mittoo S, Distler O, et al. Conference contribution Cluster-based Spondyloarthritis Phenotypes Defined at Baseline Are Predictive of Different Severity Outcomes at 5-Year in the DESIR Cohort (2019) Costantino F, Aegerter P, Molto A, Schett G, Breban M, D'Agostino MA Conference contribution